Description

Intended Use
This kit is used to quantitatively detect the nucleic acid content of hepatitis B virus (HBV) in clinical human serum and human plasma samples. It is mainly used to evaluate the level of virus replication in HBV-infected patients, rapidly screen HBV, and monitor clinical diagnosis and treatment.
Experimental operators should have received professional training in gene amplification or molecular biology method testing, and have relevant experimental operating qualifications. The laboratory should have reasonable biological safety precautions and protective procedures.
The test results of this reagent shall not be used as the only indicator for evaluating the patient’s condition, and the condition must be comprehensively analyzed in combination with the patient’s clinical manifestations and other laboratory tests.

Test Principle
This kit is based on real-time PCR fluorescence technology, the specific primers and corresponding fluorescent probes that target
the HBV genome were designed for highly specific detection. By detecting the fluorescent signals changes, the HBV from
serum or plasma specimens can be detected.